GoodRx and Novo Nordisk partnered to offer discounts on diabetes and weight-loss drugs.
5 reports, 3 independent
Updated Jul 13
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 5
- Developments
- 1
- Repetition
- 80%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
GoodRx and Novo Nordisk partnered to offer discounts on diabetes and weight-loss drugs.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
GoodRx
American prescription drug price tracking website and app
Nothing else this week.
-
Novo Nordisk
Danish pharmaceutical company
Related events
- Morgan Stanley estimates market growth for GLP-1 drugs, noting competition between Eli Lilly and Novo Nordisk.
- Eli Lilly and Novo Nordisk are competing for market share in the weight loss drug sector.
- GoodRx CEO addressed the company's underperformance on August 13, 2025, as Rite Aid bankruptcy caused stores to be removed from networks. Inquiries focused on pharma manufacturer solutions growth.
- Eli Lilly captured market share from Novo Nordisk in the weight loss drug sector.
Coverage
Newest first; wire copies grouped- StockStoryWhy GoodRx (GDRX) Stock Is Up Today Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.1% in the morning session after investor enthusiasm continued following its recent partnership with
- StockStoryGoodRx (GDRX) Stock Is Up, What You Need To Know Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.7% in the afternoon session after investor enthusiasm continued following its recent p
- Business WireGoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic® and Wegovy® for $499-Per-Month Until today, Ozempic® has not been available to eligible self-paying patients at this pric
- Yahoo FinanceGoodRx stock soars after striking deal to sell Novo Nordisk's GLP-1s for $499/month GoodRx (GDRX) is joining in on the GLP-1 action with an announcement on Monday that it will begin selling both of N